Foghorn Therapeutics Inc., a clinical-stage biotechnology company, will participate in the Evercore Biotech Diamonds in the Rough Virtual Event on Tuesday, May 27, 2025, at 2:00 p.m. EDT. Adrian Gottschalk, President and Chief Executive Officer, will be presenting during a fireside chat at the event.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.